Description: Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally. It operates in oncology and related fields, and other areas. Its products include pemetrexed disodium injection, docetaxel injection, azacitidine injection, paclitaxel injection, oxaliplatin injection, bendamustine hydrochloride injection, irinotecan injection, palonosetron hydrochloride injection, bortezomib injection, and levetiracetam injection; and sodium valproate injection, levetiracetam injection, cisatracurium besylate injection, butylphthalide injection, and milrinone injection. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorporated in 2010 and is based in Neijiang, China.
Home Page: www.huiyupharma.com
Building 3
Neijiang,
641000
China
Phone:
86 83 2880 8001
Officers
| Name | Title |
|---|---|
| Mr. Zhao Ding | Chairman and Gen. Mang. |
| Mr. Gang Cai | Mang. of Technical Department, Quality Mang. & Quality Director |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 25.3433 |
| Price-to-Book MRQ: | 2.06 |
| Price-to-Sales TTM: | 4.5749 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1480 |